Dominion Energy Inc (D) Stock News

The article highlights four software companies that have experienced significant stock declines but show strong fundamentals with double-digit revenue growth and recent rallies. Duolingo, Monday.com, Unity Software, and GitLab are positioned as potential long-term turnaround investments, each having recovered 38-145% over the past six months despite remaining well below their all-time highs.

Apple has reached a $5 trillion market valuation under new CEO John Ternus, following Tim Cook's 15-year tenure that saw the company's stock gain over 2,600%. Despite the high valuation, Apple continues to outperform the S&P 500 by double the year-to-date growth rate (27% vs 13%), driven by strong iPhone sales and its interconnected ecosystem of products. The company's measured approach to AI integration and focus on consumer hardware are attracting investor interest, though the stock's P/E ratio of 39 suggests it may be expensive for new buyers.

Despite declining Eylea sales, Regeneron's strong performance is driven by Dupixent, a blockbuster drug developed with Sanofi that generated $6 billion in global sales with 38% year-over-year growth. The company's Q2 revenue grew 17% to $4.3 billion, with Dupixent collaboration revenue jumping 51%. While Dupixent faces biosimilar competition in the early 2030s, Regeneron plans to defend its market position through improved formulations, pipeline replacements, and promising candidates like olatorepatide in the weight-loss market.

Vistra stock surged 11% following a $4.2 billion conditional DOE loan commitment to modernize three nuclear power plants, adding 433 megawatts of capacity. While the company shows strong fundamentals with 30% EBITDA growth and analyst Strong Buy ratings, investors should note the loan requires meeting technical and financial requirements, and execution risks remain around project delays and cost overruns.

Ethereum surged 66% in Q3, vastly outperforming the S&P 500's 2% gain. While the strong performance is compelling, the article cautions against overcommitting, noting Ethereum remains down 37% over five years compared to the S&P 500's 85% return. The case for buying is supported by Ethereum's growing DeFi ecosystem with $147.9 billion in stablecoins and an upcoming network upgrade, but investors should avoid excessive enthusiasm and only add to positions with non-essential funds.

AMD's stock has surged 160% in 2026, but the article argues it has become overvalued relative to its growth prospects. While AMD is growing strongly with 50% revenue growth and 107% data center growth, Nvidia is growing faster (106% overall revenue growth) and maintaining a widening lead. The author suggests AMD's future growth is already priced into the stock, making it less attractive than Nvidia at current valuations.

BioNTech has 16.6 billion euros in cash and is advancing 14 pivotal oncology trials, positioning itself to transition from a COVID-19 vaccine maker to a major cancer treatment company. With a diversified pipeline including promising candidates like pumitamig and a $1 billion share repurchase program, the company has financial flexibility to fund development. However, risks include trial failures, declining COVID-19 revenue, and regulatory delays.

Rosen Law Firm is soliciting investors for multiple securities class action lawsuits. The primary case involves Dun & Bradstreet Holdings, alleging false and misleading statements regarding a merger with Clearlake Capital Group, including omissions about executive interests and financial advisor conflicts. Additional cases involve Duolingo, Inc. and XTI Aerospace, Inc. The lead plaintiff deadline for the DNB case is November 10, 2026.

As rising interest rates may trigger a tech stock sell-off, the Invesco QQQ Trust (QQQ) is recommended as a reliable ETF to buy during market dips. QQQ tracks the Nasdaq-100 index of top non-financial tech stocks and has outperformed the S&P 500 with a 549% return over the past decade. With exposure to high-growth companies in cloud computing and AI markets expected to grow at 16% and 30.6% CAGRs respectively through 2033, QQQ offers diversified access to these secular trends at a low 0.18% expense ratio.

David Tepper's Appaloosa Management achieved a 32% return in the first half of 2026, driven by concentrated bets on three major stocks. Amazon is his largest holding after he doubled his stake, while Micron Technology and Taiwan Semiconductor Manufacturing round out his top three positions, all benefiting from AI demand trends.

Berkshire Hathaway has collected $479 million in dividends from American Express in 2025, from an initial investment of $1.3 billion made over multiple years ending in 1995. The company now owns 22% of American Express with a market value of $56 billion. American Express has consistently grown its dividend payouts over time, demonstrating the power of long-term dividend investing.

Kratos, SoundHound AI, and Nebius are high-growth companies entering compelling markets, but face a critical test: proving their growth can withstand cheaper competition. The article examines key operating metrics that could validate each company's bull case, from unmanned systems demand to AI margins and infrastructure payback periods.

Rosen Law Firm is urging Duolingo investors who purchased stock between May 2, 2025 and February 26, 2026 to join a securities class action lawsuit. The lawsuit alleges that Duolingo made false statements about user growth by concealing that increased monetization efforts, ad volume, and lower-quality AI-generated content were negatively impacting daily active users and product quality. The lead plaintiff deadline is December 7, 2026.

Johnson & Johnson reported strong Q3 results with revenue beating expectations and raised full-year guidance, driven by excellent pharmaceutical segment performance including cancer drug Darzalex and autoimmune treatment Tremfya. However, the medtech division underperformed, particularly due to safety concerns with Impella heart pumps. Despite near-term headwinds, the article argues J&J remains a solid long-term buy given its robust pharmaceutical pipeline, upcoming medtech innovations like robotic surgery devices, and its status as a Dividend King with 64 consecutive years of dividend increases.

A securities fraud class action lawsuit has been filed against AEVEX Corp. (NYSE: AVEX) for allegedly making material misstatements regarding a pre-arranged secondary public offering shortly after its April 2026 IPO. The company failed to disclose that Madison Dearborn Partners planned to waive lock-up restrictions and sell shares, causing the stock to plummet approximately 23% in early June 2026. Investors have until October 20, 2026, to file for lead plaintiff status.

Kratos Defense is betting on military demand for its autonomous Valkyrie aircraft, which has demonstrated its technology. However, the key question for investors is whether the company can convert this validation into sufficient funded production orders to justify its expanding capacity.

Rosen Law Firm reminds investors who purchased XTI Aerospace securities between April 15, 2026 and August 17, 2026 of the October 27, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges that senior executives engaged in undisclosed activities, raising doubts about disclosure controls and the company's ability to file timely earnings reports, making positive statements about the business materially misleading.

A class action lawsuit has been filed against Taboola.com Ltd. (NASDAQ: TBLA) for allegedly making materially false and misleading statements regarding its business operations. The lawsuit claims the company failed to disclose an increase in low-quality publishers and overstated the value of publisher relationships. Investors who purchased Taboola securities between May 6, 2026 and August 4, 2026 have until October 20, 2026 to apply as lead plaintiff.

Rosen Law Firm has filed a securities class action lawsuit against Celsius Holdings, Inc. (CELH) on behalf of investors who purchased securities between February 21, 2025 and June 3, 2026. The lawsuit alleges that Celsius made materially false and misleading statements regarding the cardiac risks of its Alani Nu products and inappropriately marketed these products to consumers under 18 years old. The lead plaintiff deadline is November 3, 2026.

A class action lawsuit has been filed against AEVEX Corp. alleging that the company and underwriters concealed a pre-arranged plan to prematurely override a 180-day lock-up agreement following its April 2026 IPO. The alleged scheme would have allowed Madison (the majority shareholder) to conduct a secondary public offering worth over $200 million shortly after the IPO. Investors who purchased shares during the IPO or between April 17 and June 4, 2026 have until October 20, 2026 to apply as lead plaintiff.

A class action lawsuit has been filed against Fractyl Health, Inc. (NASDAQ: GUTS) alleging that the company made materially false and misleading statements regarding its Revita product's effectiveness and clinical trial integrity. Investors who purchased Fractyl securities between January 13, 2025 and January 29, 2026 have until October 20, 2026 to apply as lead plaintiff.

The U.S. Air Force rejected Northrop Grumman's design for its Collaborative Combat Aircraft (CCA) program, awarding contracts instead to privately-held General Atomics and Anduril Industries. Undeterred, Northrop Grumman is developing the YFQ-48A Talon Blue drone independently using internal R&D funding, with plans to potentially compete in the CCA program's second increment. However, the analyst cautions that investing in Northrop based on CCA hopes is risky, citing its modest valuation metrics and growth rate.

A securities class action lawsuit has been filed against Better Home & Finance Holding Company (BETR) for allegedly making false and misleading statements about its conversion funnel and $1 billion monthly funded volume target. Investors who purchased BETR securities between March 13, 2026 and May 7, 2026 are encouraged to join the class action before the November 20, 2026 lead plaintiff deadline.

A class action lawsuit has been filed against GoDaddy Inc. for allegedly making materially false and misleading statements about customer growth and average order size during September 3, 2025 through February 24, 2026. The company promoted short-term contracts that contradicted its stated strategy, ultimately reducing average order size and bookings growth. Investors who purchased GoDaddy stock during this period have until October 20, 2026 to apply as lead plaintiff.

High diesel prices driven by a Strait of Hormuz supply disruption are benefiting energy companies differently. Marathon Petroleum, a pure-play refiner, is the biggest winner as it directly profits from the crack spread between crude costs and refined fuel prices. Integrated majors Chevron and ExxonMobil see meaningful but smaller gains across their larger businesses. Pipeline operators Energy Transfer and Enterprise Products Partners benefit modestly through increased volume fees, with their appeal primarily tied to steady dividend yields rather than diesel price exposure.

Medtronic is one year away from achieving Dividend King status with 49 consecutive years of dividend increases. An investor would need approximately 348 shares (costing ~$32,792) to generate $1,000 in annual dividend income at the current 3% yield. The recent MiniMed spinoff positions Medtronic to focus on higher-margin businesses, potentially enabling larger dividend increases and earnings growth of 7-8% in coming years.

Rosen Law Firm has filed a securities class action lawsuit against The Ensign Group, Inc. (ENSG) on behalf of investors who purchased securities between February 10, 2022 and June 18, 2026. The lawsuit alleges that Ensign made false and misleading statements regarding its business practices, including systematic neglect of elderly residents, inadequate care, Medicare/Medicaid fraud, falsification of staffing hours, and illegal licensing schemes. Investors who wish to serve as lead plaintiff must file by December 7, 2026.

The Schwab U.S. Dividend Equity ETF (SCHD) has gained 26% over the past year as investors rotate money away from crowded AI and tech stocks into dividend-paying companies. The ETF, which has less than 10% tech exposure and focuses on established blue-chip dividend payers, offers a 3.07% yield, low 0.06% expense ratio, and fair valuation metrics, making it an attractive portfolio complement.

Rosen Law Firm is reminding investors who purchased Qfin Holdings securities between March 18, 2026 and August 25, 2026 of an important November 30, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges that Qfin made false and misleading statements about the resiliency of its business and downplayed the negative impact of regulatory headwinds on its financial results.

Rosen Law Firm is urging FuelCell Energy (FCEL) investors who purchased securities between June 24, 2026 and September 1, 2026 to join a class action lawsuit. The lawsuit alleges that FuelCell made false statements about its business, concealing inadequate manufacturing capacity, slower production rates, higher costs, and likely CEPA-related charges that materially misled investors. The lead plaintiff deadline is November 10, 2026.